On-Demand Education
Disclosure
Joseph Bocchini, MD, FAAP, has disclosed that he sits on advisory panels for Pfizer, Avalere, Sobi, Moderna, and Valneva. He is also a Site PI for clinical trials with Regeneron. All remaining faculty, Louisiana AAP Education Committee members and staff have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated.
Accreditation
The Louisiana AAP is accredited by the Texas Medical Association to provide continuing medical education for physicians.
Credit
The Louisiana AAP designates this enduring material activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For additional information, contact the Louisiana AAP Education Department at CME@laaap.org.
CME Deadline
CME credit will be available for this activity until October 31, 2024.
Activity recorded on October 19, 2023.
Webinar Resources
AAP RSV Prevention: https://www.aap.org/en/patient-care/respiratory-syncytial-virus-rsv-prevention/
CDC RSV Preventive Antibody PDF: https://www.cdc.gov/vaccines/vpd/rsv/downloads/Immunization-Information-Statement.pdf
MedWatch: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
Nirsevimab Coding and Billing Sheet: https://www.laaap.org/wp-content/uploads/2023/10/MAT-US-2304812-v1.0-08-2023-Beyfortus-Coding-Billing-Sheet-FINAL.pdf